Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Coronavirus | Review

Transplantation during the COVID-19 pandemic: nothing noble is accomplished without danger

Authors: Gabriele Spoletini, Giuseppe Bianco, Dario Graceffa, Quirino Lai

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

The global health crisis due to the fast spread of coronavirus disease (COVID-19) has caused major disruption in all aspects of healthcare. Transplantation is one of the most affected sectors, as it relies on a variety of services that have been drastically occupied to treat patients affected by COVID-19. With this report from two transplant centers in Italy, we aim to reflect on resource organization, organ allocation, virus testing and transplant service provision during the course of the pandemic and to provide actionable information highlighting advantages and drawbacks.
To what extent can we preserve the noble purpose of transplantation in times of increased danger? Strategies to minimize risk exposure to the transplant population and health- workers include systematic virus screening, protection devices, social distancing and reduction of patients visits to the transplant center. While resources for the transplant activity are inevitably reduced, new dilemmas arise to the transplant community: further optimization of time constraints during organ retrievals and implantation, less organs and blood products donated, limited space in the intensive care unit and the duty to maintain safety and outcomes.
Literature
4.
go back to reference Team TNCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Wkly. 2020;2(8):113–22. Team TNCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Wkly. 2020;2(8):113–22.
6.
go back to reference Polak WG, Fondevila C, Karam V, et al. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European liver and intestine transplantation association (ELITA) and European liver transplant registry (ELTR). Transpl Int. 2020. doi:https://doi.org/10.1111/tri.13680. Published online July 1, 2020. Polak WG, Fondevila C, Karam V, et al. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European liver and intestine transplantation association (ELITA) and European liver transplant registry (ELTR). Transpl Int. 2020. doi:https://​doi.​org/​10.​1111/​tri.​13680. Published online July 1, 2020.
18.
go back to reference Chan JF-W, Yip CC-Y, To KK-W, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 2020. doi:https://doi.org/10.1128/JCM.00310-20. Published online March 4, 2020. Chan JF-W, Yip CC-Y, To KK-W, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol 2020. doi:https://​doi.​org/​10.​1128/​JCM.​00310-20. Published online March 4, 2020.
19.
go back to reference Lieberman JA, Pepper G, Naccache SN, Huang M-L, Jerome KR, Greninger AL. Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020. https://doi.org/10.1128/JCM.00821-20 Published online April 29, 2020. Lieberman JA, Pepper G, Naccache SN, Huang M-L, Jerome KR, Greninger AL. Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020. https://​doi.​org/​10.​1128/​JCM.​00821-20 Published online April 29, 2020.
20.
go back to reference Rhoads DD, Cherian SS, Roman K, Stempak LM, Schmotzer CL, Sadri N. Comparison of Abbott ID now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J Clin Microbiol. 2020. doi:https://doi.org/10.1128/JCM.00760-20. Published online April 17, 2020. Rhoads DD, Cherian SS, Roman K, Stempak LM, Schmotzer CL, Sadri N. Comparison of Abbott ID now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J Clin Microbiol. 2020. doi:https://​doi.​org/​10.​1128/​JCM.​00760-20. Published online April 17, 2020.
Metadata
Title
Transplantation during the COVID-19 pandemic: nothing noble is accomplished without danger
Authors
Gabriele Spoletini
Giuseppe Bianco
Dario Graceffa
Quirino Lai
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01401-0

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine